首页> 外文期刊>Clinical and experimental hypertension: CEH >Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.
【24h】

Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL.

机译:血管紧张素II受体阻滞剂对24小时血压,自主神经功能和健康相关QOL之间关系的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

We report the relationship between 24-hour (24-h) blood pressure, autonomic function, and health-related quality of life (HRQOL) in normotensives and hypertensives. The aim of this study was to determine whether there is a relationship between 24-h blood pressure, autonomic function, and HRQOL during treatment with an angiotensin receptor blocker (ARB) in patients with hypertension. Thirteen patients with hypertension were randomly treated with losartan (25-50 mg, n = 5), candesartan (4-8 mg, n = 4), valsartan (80 mg, n = 1), telmisartan (40 mg, n = 2), and olmesartan (10 mg, n = 1), daily. 24-h ambulatory blood pressure (BP) was measured before treatment and 3 months after treatment. Sympathetic nervous activity (the ratio of low frequency to high frequency component (LF/HF)) and parasympathetic nervous activity (high frequency component (HF)) were calculated by analyzing heart rate variability. HRQOL was assessed using a medical outcome study short-form 36-item health survey (SF-36) questionnaire. All of the participants completed the study. Angiotensin receptor blocker treatment reduced 24-h mean BP (MBP) from 107 +/- 9 to 100 +/- 9 mmHg. 24-h MBP positively correlated with 24-h LF/HF in all subjects who received ARB (R = 0.568, p < 0.04). There were no differences in heart rate, serum albumin level, BUN level, creatinine level, potassium level, or HRQOL score. These findings indicated that ARB reduced BP; however, treatment with ARB did not affect the scores of HRQOL and the relationship between 24-h blood pressure and autonomic function.
机译:我们报告血压和高血压中24小时(24小时)血压,自主神经功能和健康相关生活质量(HRQOL)之间的关系。这项研究的目的是确定高血压患者使用血管紧张素受体阻滞剂(ARB)治疗期间24小时血压,自主神经功能和HRQOL是否相关。 13名高血压患者随机接受氯沙坦(25-50 mg,n = 5),坎地沙坦(4-8 mg,n = 4),缬沙坦(80 mg,n = 1),替米沙坦(40 mg,n = 2)治疗)和奥美沙坦(10 mg,n = 1),每天服用。治疗前和治疗后3个月测量24小时动态血压(BP)。通过分析心率变异性来计算交感神经活动(低频分量与高频分量之比(LF / HF))和副交感神经活动(高频分量(HF))。使用医学结果研究简短的36项健康调查(SF-36)问卷对HRQOL进行了评估。所有参与者均完成了研究。血管紧张素受体阻滞剂治疗可将24小时平均BP(MBP)从107 +/- 9 mmHg降低至100 +/- 9 mmHg。在接受ARB的所有受试者中,24 h MBP与24 h LF / HF呈正相关(R = 0.568,p <0.04)。心率,血清白蛋白水平,BUN水平,肌酐水平,钾水平或HRQOL评分无差异。这些发现表明ARB降低了血压。然而,ARB治疗并没有影响HRQOL评分以及24小时血压与自主神经功能之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号